EVEREST GROUP, LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 364.7 USD | -0.29% |
|
-2.18% | +3.14% |
| Apr. 25 | Everest Medicines' Loss Widens in 2023 | MT |
| Apr. 24 | India inspects facilities of spice makers MDH and Everest, regulator says | RE |
Financials (USD)
| Sales 2024 * | 17.24B | Sales 2025 * | 18.66B | Capitalization | 17.83B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.66B | Net income 2025 * | 3.01B | EV / Sales 2024 * | 1.03 x |
| Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.96 x |
| P/E ratio 2024 * |
6
x | P/E ratio 2025 * |
5.31
x | Employees | 2,844 |
| Yield 2024 * |
1.96% | Yield 2025 * |
2.07% | Free-Float | 62.6% |
More Fundamentals
* Assessed data
More news
Latest transcript on Everest Group, Ltd.
More recommendations
More press releases
| 1 day | -0.29% | ||
| 1 week | -2.18% | ||
| Current month | -8.25% | ||
| 1 month | -7.86% | ||
| 3 months | -3.39% | ||
| 6 months | -5.42% | ||
| Current year | +3.14% |
1 week
361.44
376.00
1 month
354.08400.75
Current year
343.76400.75
1 year
331.08417.92
3 years
234.87417.92
5 years
157.32417.92
10 years
155.23417.92
| Managers | Title | Age | Since |
|---|---|---|---|
Juan Andrade
CEO | Chief Executive Officer | 58 | 19-08-31 |
Mike Karmilowicz
CHM | Chairman | 55 | - |
Mark Kociancic
DFI | Director of Finance/CFO | 54 | 20-10-11 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Meryl Hartzband
BRD | Director/Board Member | 69 | 19-05-22 |
John Amore
BRD | Director/Board Member | 75 | 12-09-18 |
Juan Andrade
CEO | Chief Executive Officer | 58 | 19-08-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 14.79% | 215 M€ | +10.68% | - | |
| 2.07% | 16 M€ | -3.37% | ||
| 0.51% | 393 M€ | +5.25% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 365.8 | +0.01% | 330,787 |
| 24-04-24 | 365.7 | -0.79% | 335,991 |
| 24-04-23 | 368.7 | -1.12% | 285,044 |
| 24-04-22 | 372.8 | +0.70% | 233,613 |
| 24-04-19 | 370.3 | +2.79% | 425,229 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm EDT
More quotes
Everest Group, Ltd. (formerly Everest Re Group, Ltd.) is a reinsurance group organized around 2 areas of activity:
- non-life reinsurance (73.5% of gross written premiums): real estate, damage, health, accidents, maritime reinsurance, etc.;
- insurance (26.5%): real estate and casualty insurance.
Sector
Reinsurance
Calendar
2024-04-29
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
365.8
USD
Average target price
431
USD
Spread / Average Target
+17.84%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +3.14% | 17.83B | |
| +10.24% | 60.64B | |
| +11.78% | 11.58B | |
| +4.14% | 2.02B | |
| -8.29% | 1.55B | |
| +5.54% | 979M | |
| -4.40% | 653M | |
| +39.78% | 618M | |
| +5.52% | 430M | |
| +20.52% | 391M |
- Stock Market
- Equities
- EG Stock
